Abstract

Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders, such as atherosclerosis, obesity, and type 2 diabetes. Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders. In this paper, we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk, focusing on the newest findings in this field.
Lingua originaleEnglish
pagine (da-a)120-127
Numero di pagine8
RivistaCurrent Cardiology Reports
Volume17
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • Cardiovascular disease
  • Gut microbiota
  • Obesity
  • Platelets
  • Type 2 diabetes

Fingerprint

Entra nei temi di ricerca di 'Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk'. Insieme formano una fingerprint unica.

Cita questo